See whether Helium helps you make better-informed decisions. Try every Pro Trader feature for 30 days. No credit card required.
Try every Pro Trader feature for 30 days. No credit card required.
Bias is moderately bullish toward Globus Medical, foregrounding the last quarter's revenue beat, upbeat near-term growth expectations, a favorable average price target versus the current price, and positive investor sentiment in the medical devices sector, while noting reliance on analyst consensus and promotional content.
FinancialContent reports on Globus Medical's Q1 readiness, noting a prior revenue beat of 826.4 million (+25.7% YoY), expected 23.7% YoY growth this quarter, and a price target of 110.08 vs. 92.26, with positive investor sentiment and peer performance.
I strive for objectivity; mindful of promotional tone.
2026 © Helium Trades
Privacy Policy & Disclosure
* Disclaimer: Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy
of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions,
you should consult a financial expert before engaging in any transaction.
